Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT few

被引：1
|
作者：
Liuzzo, Giovanna [1 ,2 ]
Patrono, Carlo [1 ,3 ]
机构：
[1] Catholic Univ, Dept Cardiovasc & Pulm Sci, Sch Med, Largo F Vito 1, I-00168 Rome, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Sci, Largo A Gemelli 8, I-00168 Rome, Italy
[3] Catholic Univ, Dept Pharmacol, Sch Med, Largo F Vito 1, I-00168 Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷 / 08期
关键词：
MORTALITY;
D O I：
10.1093/eurheartj/ehad823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：570 / 571
页数：2
相关论文
共 50 条
  • [1] Semaglutide and cardiovascular outcomes by blood pressure in the SELECT trial
    Verma, Subodh
    Deanfield, John
    Arbel, Yaron
    Cariou, Bertrand
    Matos, Ana Laura S. A.
    Hovingh, G. Kees
    Jeppesen, Ole Kleist
    Kahn, Steven
    Latkovskis, Gustavs
    Lingvay, Ildiko
    Maeng, Michael
    Maher, Vincent
    Parkhomenko, Oleksandr
    Poulter, Neil
    van de Borne, Philippe
    Kure, Peter
    Lincoff, Abraham
    CIRCULATION, 2024, 150
  • [2] Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) Outcomes by Sex
    Verma, Subodh
    Colhoun, Helen M.
    Dicker, Dror
    Hovingh, G. Kees
    Kahn, Steven E.
    Kautzky-Willer, Alexandra
    Lingvay, Ildiko
    Plutzky, Jorge
    Rasmussen, Soren
    Rathor, Naveen
    Tetens, Soren
    Lincoff, A. Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (17) : 1678 - 1682
  • [3] SEMAGLUTIDE, INFLAMMATORY MARKERS AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH OVERWEIGHT OR OBESITY IN THE SELECT TRIAL
    Plutzky, Jorge
    Bogdanski, Pawel
    Dagdelen, Selcuk
    Deanfield, John
    Emerson, Scott
    Hovingh, G.
    Kahn, Steven
    Larsen, Signe
    Latkovskis, Gustavs
    Lehrke, Michael
    Hardt-Lindberg, Soren
    Lingvay, Ildiko
    Nicholls, Stephen
    Oral, Tugce
    Terns, Paula Perez
    Rasmussen, Soren
    Ridker, Paul
    Ryan, Donna
    Lincoff, A. Michael
    ATHEROSCLEROSIS, 2024, 395
  • [4] Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
    Ryan, Donna H.
    Lingvay, Ildiko
    Colhoun, Helen M.
    Deanfield, John
    Emerson, Scott S.
    Kahn, Steven E.
    Kushner, Robert F.
    Marso, Steve
    Plutzky, Jorge
    Brown-Frandsen, Kirstine
    Gronning, Marianne O. L.
    Hovingh, G. Kees
    Holst, Anders Gaarsdal
    Ravn, Henrik
    Lincoff, A. Michael
    AMERICAN HEART JOURNAL, 2020, 229 : 61 - 69
  • [5] Semaglutide and Cardiovascular Outcomes
    Belkhouribchia, Jamal
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (08): : 767 - 767
  • [6] SELECT semaglutide to improve outcomes in patients with obesity and cardiovascular disease, also without diabetes
    Gajos, Grzegorz
    CARDIOLOGY JOURNAL, 2024, 31 (05) : 782 - 783
  • [7] Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
    Colhoun, Helen M.
    Lingvay, Ildiko
    Brown, Paul M.
    Deanfield, John
    Brown-Frandsen, Kirstine
    Kahn, Steven E.
    Plutzky, Jorge
    Node, Koichi
    Parkhomenko, Alexander
    Ryden, Lars
    Wilding, John P. H.
    Mann, Johannes F. E.
    Tuttle, Katherine R.
    Idorn, Thomas
    Rathor, Naveen
    Lincoff, A. Michael
    NATURE MEDICINE, 2024, 30 (07) : 2058 - 2066
  • [8] Semaglutide improves cardiovascular outcomes in patients with high risk of metabolic dysfunction-associated steatohepatitis - a subgroup analysis from the SELECT trial
    George, Jacob
    Meyhofer, Sebastian
    Cariou, Bertrand
    Cercato, Cintia
    Colhoun, Helen
    Duun-Henriksen, Anne Katrine
    Kliers, Iris
    Lincoff, A. Michael
    Lingvay, Ildiko
    Long, Michelle
    Newsome, Philip N.
    Nicholls, Stephen
    Pelaez, Maria De Los Angeles Quiroga
    Santini, Ferruccio
    Sanyal, Arun J.
    Kahn, Steven
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 68 - 69
  • [9] Semaglutide and Cardiovascular Outcomes REPLY
    Lincoff, A. Michael
    Ryan, Donna H.
    Esbjerg, Sille
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (08): : 768 - 769
  • [10] Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
    Deanfield, John
    Verma, Subodh
    Scirica, Benjamin M.
    Kahn, Steven E.
    Emerson, Scott S.
    Ryan, Donna
    Lingvay, Ildiko
    Colhoun, Helen M.
    Plutzky, Jorge
    Kosiborod, Mikhail N.
    Hovingh, G. Kees
    Hardt-Lindberg, Soren
    Frenkel, Ofir
    Weeke, Peter E.
    Rasmussen, Soren
    Goudev, Assen
    Lang, Chim C.
    Urina-Triana, Miguel
    Pietilae, Mikko
    Lincoff, A. Michael
    ELECT Trial Investigators, S. E. L. E. C. T. Trial Investigators
    LANCET, 2024, 404 (10454): : 773 - 786
12345